Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers

NCT00832091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Stasis Ulcers

Interventions

DRUG: Thymosin Beta 4
DRUG: Placebo

Sponsor

RegeneRx Biopharmaceuticals, Inc.

Collaborators

[object Object]